688520 神州细胞
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-41.22894.728224.112-475.870-227.230
总资产报酬率 ROA (%)5.106-14.521-25.261-57.092-57.653
投入资产回报率 ROIC (%)6.334-18.787-35.586-85.652-58.440

边际利润分析
销售毛利率 (%)96.28397.11096.68994.76181.944
营业利润率 (%)27.3690.337-34.958-637.576-217,561.313
息税前利润/营业总收入 (%)11.824-15.291-42.225-624.971-213,149.714
净利润/营业总收入 (%)7.765-21.026-50.827-646.514-217,591.211

收益指标分析
经营活动净收益/利润总额(%)317.6265.63675.009102.089107.663
价值变动净收益/利润总额(%)0.719-0.624-1.174-1.125-1.389
营业外收支净额/利润总额(%)-252.452101.60431.2231.3830.014

偿债能力分析
流动比率 (X)0.7090.5231.1160.8852.319
速动比率 (X)0.5880.4230.9760.7502.229
资产负债率 (%)104.243122.285108.852116.82264.631
带息债务/全部投入资本 (%)95.026114.83269.03598.459--
股东权益/带息债务 (%)-5.213-24.270-16.601-27.002177.157
股东权益/负债合计 (%)-3.891-18.032-7.946-14.12054.953
利息保障倍数 (X)2.913-2.667-4.908-29.010-47.991

营运能力分析
应收账款周转天数 (天)64.46860.37460.424218.5680.000
存货周转天数 (天)829.4931,302.1971,496.6883,297.9200.000